Yellowstone Biosciences

Ypsilon Therapeutics

The company develops T-cell receptor mimic antibodies and bispecific T-cell engagers to treat patients with solid tumours, such as triple-negative breast and lung cancer.

Immunocore

This biotechnology company develops T cell receptor immunotherapies to treat patients with cancer, infectious diseases and autoimmune conditions.

T-Therapeutics

The company develops T cell receptor therapeutics and bispecific engagers for patients with cancer and autoimmune diseases.

PanCancerT

This biotech company develops T-cell receptor therapies for patients with solid tumours, focusing on targets like triple-negative breast cancer and melanoma.

Hillstar Bio

This biotechnology company develops precision immunology therapies that target and deplete pathogenic immune cells for patients with autoimmune diseases.

Yarrow Bioscience

This biotechnology company develops monoclonal antibody therapies for patients with autoimmune thyroid conditions, including Graves' disease and thyroid eye disease.

Reverb Therapeutics

This biotechnology company develops bispecific antibody therapies that redirect the body's natural cytokines to treat patients with cancer and autoimmune diseases.

3T Biosciences

The company develops T-cell receptor therapeutics and target identification technologies for oncology patients to treat solid tumours.